Building upon the current mechanistic insights, natural products interacting with the bonevascularimmune microenvironment, particularly through biomaterial-facilitated delivery, offer a promising foundation for next-generation therapies targeting bone degenerative diseases
Future developments will likely expand on this, allowing for truly individualized IV drips that account for a patient's precise deficiencies, inflammatory markers, and even their unique drug metabolism pathways, ensuring that each patient receives exactly what their body needs at the right time
Mitochondrial protection: BPC-157 preserves mitochondrial function during stress reducing ROS production from dysfunctional electron transport chains
This further prevents other complications which present secondarily to obesity, such as kidney disease, cardiovascular disease, and liver disease